News

Patient Involvement in Publications – European Hematology Association

Envision’s Dawn Lobban raised the profile of patient involvement in publications during a presentation at the recent 23rd congress of the European Hematology Association (June 14-17, 2018, Stockholm, Sweden).

The session was hosted by the European Patients’ Academy on Therapeutic Innovation (EUPATI), and was attended by around 50 patient representatives from different patient advocacy groups.

Dawn covered the current landscape of patient involvement in publications, and “traps and tips” to inform and support patients considering publishing their research. The audience were clearly engaged with this topic, which covers new ground for EUPATI’s patient education programme.

“I really enjoyed discussing scientific publications with the patient advocates attending EHA! There was a lot of interest from this audience in participating as co-authors on relevant clinical publications, as well as publishing their own data in scientific journals – this will really help to build this important body of evidence.” Dawn Lobban, Envision Pharma Group, ISMPP EU Committee Member 2018.

Dawn attended EHA as part of Envision the Patient, our dedicated strategic framework for patient involvement initiatives. If you would like a copy of the presentation, or to discuss Envision’s patient-focused offerings, please get in touch with the team.